{"log_id": 2689613698451993125, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.004598, "average": 0.977422, "min": 0.634865}, "location": {"width": 776, "top": 223, "height": 48, "left": 173}, "words": "图2.独立评估的既往舒尼替尼治疗亚组的无进展生存期的 Kaplan- Meier曲线"}, {"probability": {"variance": 0.001173, "average": 0.966648, "min": 0.925067}, "location": {"width": 122, "top": 320, "height": 22, "left": 774}, "words": " NLYTA(N=194)"}, {"probability": {"variance": 0, "average": 0.960073, "min": 0.960073}, "location": {"width": 19, "top": 348, "height": 17, "left": 768}, "words": " Me"}, {"probability": {"variance": 0, "average": 0.973281, "min": 0.973281}, "location": {"width": 18, "top": 346, "height": 17, "left": 890}, "words": " th"}, {"probability": {"variance": 0.017771, "average": 0.934193, "min": 0.538244}, "location": {"width": 199, "top": 381, "height": 38, "left": 714}, "words": " o- Sorafenib(N=195)"}, {"probability": {"variance": 2.2e-05, "average": 0.993902, "min": 0.98925}, "location": {"width": 71, "top": 409, "height": 20, "left": 770}, "words": " Median 3"}, {"probability": {"variance": 0.000471, "average": 0.985882, "min": 0.948439}, "location": {"width": 152, "top": 454, "height": 22, "left": 769}, "words": " Hazard Ratio= 0.74"}, {"probability": {"variance": 0.018567, "average": 0.922332, "min": 0.589993}, "location": {"width": 139, "top": 478, "height": 23, "left": 771}, "words": "95%Cl[0.58,0.94"}, {"probability": {"variance": 0.006521, "average": 0.960523, "min": 0.724996}, "location": {"width": 108, "top": 503, "height": 20, "left": 791}, "words": "alue=0.0063"}, {"probability": {"variance": 0.012642, "average": 0.887562, "min": 0.775124}, "location": {"width": 36, "top": 718, "height": 18, "left": 611}, "words": " nths)"}, {"probability": {"variance": 0.027362, "average": 0.671022, "min": 0.505609}, "location": {"width": 117, "top": 717, "height": 55, "left": 852}, "words": "深不"}, {"probability": {"variance": 0.00382, "average": 0.974172, "min": 0.682538}, "location": {"width": 771, "top": 808, "height": 49, "left": 182}, "words": "图3.独立评估的既往细胞因子治疗亚组的无进展生存期的 Kaplan- Meier曲线"}, {"probability": {"variance": 1.3e-05, "average": 0.995616, "min": 0.991812}, "location": {"width": 120, "top": 900, "height": 21, "left": 774}, "words": " NLYTA(N=126)"}, {"probability": {"variance": 0, "average": 0.99509, "min": 0.99509}, "location": {"width": 17, "top": 928, "height": 16, "left": 765}, "words": "M"}, {"probability": {"variance": 0.000106, "average": 0.989688, "min": 0.979375}, "location": {"width": 86, "top": 925, "height": 18, "left": 834}, "words": " 12.0 month"}, {"probability": {"variance": 0.000597, "average": 0.943095, "min": 0.903189}, "location": {"width": 52, "top": 969, "height": 25, "left": 691}, "words": "--0-"}, {"probability": {"variance": 0.005204, "average": 0.920051, "min": 0.836973}, "location": {"width": 141, "top": 961, "height": 22, "left": 771}, "words": " Sorafenib(N=125)"}, {"probability": {"variance": 0, "average": 0.78359, "min": 0.78359}, "location": {"width": 43, "top": 991, "height": 17, "left": 769}, "words": " Medi"}, {"probability": {"variance": 8.2e-05, "average": 0.850924, "min": 0.841879}, "location": {"width": 16, "top": 989, "height": 16, "left": 890}, "words": "th"}, {"probability": {"variance": 0.000563, "average": 0.980332, "min": 0.941913}, "location": {"width": 153, "top": 1033, "height": 22, "left": 770}, "words": " Hazard Ratio= 0. 52"}, {"probability": {"variance": 0.026805, "average": 0.923508, "min": 0.438116}, "location": {"width": 137, "top": 1058, "height": 21, "left": 772}, "words": "95%C[0.38,0.72"}, {"probability": {"variance": 0, "average": 0.83119, "min": 0.83119}, "location": {"width": 16, "top": 1087, "height": 16, "left": 770}, "words": "P"}, {"probability": {"variance": 6.2e-05, "average": 0.994501, "min": 0.978818}, "location": {"width": 49, "top": 1083, "height": 18, "left": 845}, "words": "0.000"}, {"probability": {"variance": 0, "average": 0.997605, "min": 0.997605}, "location": {"width": 17, "top": 1283, "height": 17, "left": 540}, "words": "T"}, {"probability": {"variance": 0.027978, "average": 0.832733, "min": 0.665466}, "location": {"width": 35, "top": 1282, "height": 18, "left": 617}, "words": " Iths)"}, {"probability": {"variance": 0.00233, "average": 0.965832, "min": 0.824817}, "location": {"width": 278, "top": 1384, "height": 40, "left": 191}, "words": "研究A4061051(亚洲研究)"}, {"probability": {"variance": 1.2e-05, "average": 0.99889, "min": 0.978924}, "location": {"width": 799, "top": 1424, "height": 52, "left": 239}, "words": "该研究是在亚洲区域开展的随机、对照、开放、多中心研究。在既往一线全身治疗"}, {"probability": {"variance": 6.1e-05, "average": 0.995356, "min": 0.973706}, "location": {"width": 141, "top": 1581, "height": 26, "left": 550}, "words": "第19页,共27页"}, {"probability": {"variance": 0.001311, "average": 0.973686, "min": 0.888567}, "location": {"width": 96, "top": 1615, "height": 22, "left": 257}, "words": "No:20150429"}], "language": 3}